Genmab A/S (GNMSF) Total Debt (2019 - 2026)
Genmab A's (GNMSF) quarterly Total Debt came in at $4.9 billion in Q1 2026, up 3349.65% YoY from $143.0 million in Q1 2025, and down 6.47% on a QoQ basis from $5.3 billion in Q4 2025.
Genmab A/S (GNMSF) Total Debt (2019 - 2026) Analysis & Trends
Genmab A (GNMSF) has 4 years of Total Debt data on file, last reported at $4.9 billion in Q1 2026.
- Quarterly Total Debt rose 3349.65% year-over-year to $4.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 billion (up 3349.65% YoY) and the FY2025 annual result came in at $5.3 billion, changed N/A from the prior year.
- Total Debt fell to $4.9 billion in Q1 2026, from $5.3 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $5.3 billion in Q4 2025 to a low of $143.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.14 Bn |
| Mar 31, 2026 | 4.93 Bn |
| Dec 31, 2025 | 5.27 Bn |
| Mar 31, 2025 | 143.00 Mn |
| Sep 30, 2020 | 337.00 Mn |
| Dec 31, 2019 | 181.00 Mn |
| Sep 30, 2019 | 188.61 Mn |